Eyestem Research
PrivateLast Round
Series B
Aug 11, 2025
Est. Valuation
$67M
Total Funding Raised
$16.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eyestem Research is a clinical-stage biotechnology company developing scalable cell replacement therapies for incurable eye diseases, with a lead product targeting Dry Age-related Macular Degeneration (AMD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eyestem Research Comparables
Compare Eyestem Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Luxa Biotechnology | 85% | |
| Regenerative Patch Technologies | 84% | |
| Roche Holding | 80% | |
Eyestem Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 11, 2025 | ||||
| Series A | Aug 8, 2022 | ||||
| Seed | May 26, 2021 | ||||
| Seed | Jan 7, 2021 | ||||
| Seed | Jan 20, 2020 | ||||
Seed | Jul 25, 2019 |
Key People
Founding team and executive leadership
Eyestem Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Endiya Partners | Series B, Series A, Seed |
| HealthCrest | Seed |
| Kotak Alternate Asset Managers | Seed, Series A |
| Centre for Cellular and Molecular Platforms | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2025
$10M round with a $57M pre-money valuation.
- Aug 11, 2025
$10M raised to advance investigational cell therapy.
Eyestem Research Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eyestem Research's valuation, stock price, and market status.